{"id":3457,"date":"2022-12-16T14:35:54","date_gmt":"2022-12-16T14:35:54","guid":{"rendered":"https:\/\/indiamedicine.org\/?p=3457"},"modified":"2022-12-16T14:35:56","modified_gmt":"2022-12-16T14:35:56","slug":"paxlovid-conditions-of-use","status":"publish","type":"post","link":"https:\/\/indiamedicine.org\/?p=3457","title":{"rendered":"PAXLOVID &#8211; CONDITIONS OF USE"},"content":{"rendered":"\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/indiamedicine.org\/wp-content\/uploads\/2022\/12\/paxlovid-pf-07321332-ritonavir-covid-19-article-53-procedure-conditions-use-conditions-distribution_en.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of paxlovid-pf-07321332-ritonavir-covid-19-article-53-procedure-conditions-use-conditions-distribution_en.\"><\/object><a id=\"wp-block-file--media-af89f70d-6b3f-47cd-b7d8-0d4540367ae1\" href=\"https:\/\/indiamedicine.org\/wp-content\/uploads\/2022\/12\/paxlovid-pf-07321332-ritonavir-covid-19-article-53-procedure-conditions-use-conditions-distribution_en.pdf\">paxlovid-pf-07321332-ritonavir-covid-19-article-53-procedure-conditions-use-conditions-distribution_en<\/a><a href=\"https:\/\/indiamedicine.org\/wp-content\/uploads\/2022\/12\/paxlovid-pf-07321332-ritonavir-covid-19-article-53-procedure-conditions-use-conditions-distribution_en.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-af89f70d-6b3f-47cd-b7d8-0d4540367ae1\">Download<\/a><\/div>\n\n\n\n<p><\/p>\n\n\n\n<p>MEDICINAL PRODUCT FOR USE<\/p>\n\n\n\n<p>1. Name of the medicinal product for use: PAXLOVID <\/p>\n\n\n\n<p>2. Active substance(s): Nirmatrelvir\u00a0and ritonavir <\/p>\n\n\n\n<p>3. Pharmaceutical form: Film-coated tablets <\/p>\n\n\n\n<p>4. Route of administration: Oral use <\/p>\n\n\n\n<p>5. Strength: 150 mg Nirmatrelvir\u00a0, 100 mg ritonavir<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MEDICINAL PRODUCT FOR USE 1. Name of the medicinal product for use: PAXLOVID 2. Active substance(s): Nirmatrelvir\u00a0and ritonavir 3. Pharmaceutical form: Film-coated tablets 4. Route of administration: Oral use 5. Strength: 150 mg Nirmatrelvir\u00a0, 100 mg ritonavir<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[18],"tags":[],"class_list":["post-3457","post","type-post","status-publish","format-standard","hentry","category-news","entry"],"_links":{"self":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3457"}],"version-history":[{"count":1,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3457\/revisions"}],"predecessor-version":[{"id":3459,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=\/wp\/v2\/posts\/3457\/revisions\/3459"}],"wp:attachment":[{"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3457"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indiamedicine.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}